Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
前日終値
$37.72
+$1.72 · +4.78%
日中の時刻はETです。市場データは遅延する場合があります。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日中レンジ
現在 $37.72
52週レンジ
現在 $37.72
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
54
まちまち
リスク
55
やや高いリスク
モメンタム
39
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日中レンジ
現在 $37.72
52週レンジ
現在 $37.72
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 5.94億 USD | 5.73億 USD | 6.65億 USD | 5.55億 USD | 5.14億 USD |
| 売上原価 | 3.24億 USD | 3.19億 USD | 4.32億 USD | 3.25億 USD | 2.99億 USD |
| 粗利益 | 2.7億 USD | 2.55億 USD | 2.33億 USD | 2.31億 USD | 2.15億 USD |
| 研究開発 | 3039万 USD | 3152.4万 USD | 3395.6万 USD | 2754.2万 USD | 2241.2万 USD |
| 販売・一般管理 | 2.51億 USD | 2.53億 USD | 2.81億 USD | 2.27億 USD | 1.89億 USD |
| 営業費用 | 2.82億 USD | 2.85億 USD | 3.15億 USD | 2.55億 USD | 2.11億 USD |
| 受取利息 | 1877.9万 USD | 3317.7万 USD | 4373.5万 USD | 2028.6万 USD | 63.2万 USD |
| 支払利息 | — | — | — | 458.9万 USD | 203.7万 USD |
| 減価償却費と償却費 | 6120.9万 USD | 9074.4万 USD | 8558.4万 USD | 5370.2万 USD | 5687.2万 USD |
| 営業利益 | −1126.8万 USD | −2998.1万 USD | −8219.8万 USD | −2402.3万 USD | 359.6万 USD |
| 純利益 | −5576.3万 USD | −1.65億 USD | −1425.7万 USD | −4.29億 USD | 1.11億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$43.00
上昇余地(14.00%)分割調整後の1株当たりの年間現金分配金。
$0.40
2021年(通年)0.0% 以来 2017
$0.40
2,017
$0.40
2,018
$0.40
2,019
$0.40
2,020
$0.40
2,021
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2021年12月2日 | $0.10Quarterly | 2021年12月3日 | 2021年12月23日 |
配当 | 2021年9月2日 | $0.10Quarterly | 2021年9月3日 | 2021年9月24日 |
配当 | 2021年6月3日 | $0.10Quarterly | 2021年6月4日 | 2021年6月25日 |
配当 | 2021年3月4日 | $0.10Quarterly | 2021年3月5日 | 2021年3月26日 |
配当 | 2020年12月3日 | $0.10Quarterly | 2020年12月4日 | 2020年12月17日 |
配当 | 2020年9月3日 | $0.10Quarterly | 2020年9月4日 | 2020年9月25日 |
配当落ち 2021年12月2日
$0.10
Quarterly
2021年12月3日基準 · 支払日 2021年12月23日
配当落ち 2021年9月2日
$0.10
Quarterly
2021年9月3日基準 · 支払日 2021年9月24日
配当落ち 2021年6月3日
$0.10
Quarterly
2021年6月4日基準 · 支払日 2021年6月25日
配当落ち 2021年3月4日
$0.10
Quarterly
2021年3月5日基準 · 支払日 2021年3月26日
配当落ち 2020年12月3日
$0.10
Quarterly
2020年12月4日基準 · 支払日 2020年12月17日
配当落ち 2020年9月3日
$0.10
Quarterly
2020年9月4日基準 · 支払日 2020年9月25日
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core S&P Small-Cap ETFIJR8474.14万0.08%1031.91億 USD0.06%$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI4315.42万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM3995.15万0.05%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB3114.85万0.02%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR1979.14万0.03%682億 USD0.05%$234.43+0.22%
Vanguard Extended Market ETFVXF1554.29万0.02%954億 USD0.05%$235+0.80%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1397.51万0.05%268.09億 USD0.33%$37.95-0.39%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1304.16万0.08%158.4億 USD0.03%$53.45+0.17%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。